Eurofins CDMO Alphora Inc

Eurofins CDMO Alphora Inc. provides integrated solutions for small molecules, drug product, biologics and phytocannabinoids. Specializing in complex and niche small molecule drug substance and drug product services, including high potent capabilities, we provide support from preclinical to commercial development & manufacturing. For biologics, our expertise lies in the development and scaling of monoclonal antibodies (mAbs) and other mammalian-based therapeutic proteins. Our offerings include upstream & downstream development, analytical services, antibody drug conjugate (ADC) capabilities, and scale-up capacity to 200L for pre-clinical and phase I supply. Additionally, we specialize in producing pharmaceutical-grade, high-quality phytocannabinoids via synthetic routes and reference standards.

LinkedIn: https://www.linkedin.com/company/alphora-research

Twitter: https://twitter.com/eurofinscdmo